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A high fat diet (HFD) induces substantial cardiac metabolic alteration(s), but the initiating molecular
events remain unclear. We assessed the early cardiac energy metabolic changes in C57/BJ mice fed a
HFD for 10 days. Carbohydrate oxidation was markedly decreased in mice on a HFD, in which up-
regulation of pyruvate dehydrogenase kinase 4 (PDK4) was evident. Concurrently, E2F1, a transcrip-
tion factor controlling PDK4 expression, was activated, as was cyclin D1, an upstream-molecule of
E2F1, and eukaryotic initiation factor 4E (eIF4E), a modulator of cyclinD1 translation. Hence, HFD
may initiate early cardiac metabolic alterations through the eIF4E/cyclin D1/E2F1/PDK4 axis.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
A high fat diet (HFD) can lead to insulin resistance and the
development of cardiovascular diseases [1]. One of the HFD-in-
duced metabolic alterations in the heart is an increase in fatty acid
oxidation and a reduction in glucose utilization [2,3]. Competition
between fatty acids and carbohydrates can occur at the level of the
initial uptake of substrates into the cells, or at the subsequent
transport into the mitochondria. At the level of the mitochondria,
the pyruvate dehydrogenase complex (PDC) catalyzes the conver-
sion of pyruvate to acetyl-CoA, thereby controlling glucose oxida-
tion. Activity of PDC can be negatively modulated by pyruvate
dehydrogenase kinase 4 (PDK4), that in turn, is regulated at the
transcriptional level by multiple factors, including transcription
factors, such as E2F1 [4], PPARa [5], PGC-1a [6], Foxo1 [7] and
estrogen-related receptors [6].
The transcription factor E2F1, besides being a critical cell cycle
regulator, also plays an important role in controlling mitochondrial
function [8,9] and glucose homeostasis [4,10,11]. The activity ofchemical Societies. Published by E
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Lopaschuk).E2F1 is largely controlled by the phosphorylation of retinoblas-
toma (Rb), leading to dissociation of the Rb/E2F1 complex thereby
releasing E2F1 for nuclear translocation [12,13]. Phosphorylating
Rb (p-Rb), at a speciﬁc residue serine 780 (s780) by cyclin-depen-
dent kinase 4 (CDK4) [14], requires elevated cytosolic cyclin D1 to
form a complex with CDK4 [15]. Up-regulation of cytosolic free cy-
clin D1 can be regulated at the transcriptional level [16], but fre-
quently occurs as a result of post-translational modiﬁcations
[17,18]. A speciﬁc regulation of cyclin D1 translation by eukaryotic
initiation factor 4E (eIF4E) has also been demonstrated [19,20].
Two overlapping binding sites of E2F1 on the PDK4 promoter
have been identiﬁed [4]. Over-expression of E2F1 in C2C12 myo-
blasts up-regulates PDK4 expression and suppresses glucose oxida-
tion [4]. Conversely, inhibition of E2F1 prevents the development
of myocyte hypertrophy in vitro [21], while loss of E2F1 in vivo
blunts PDK4 expression and increases cardiac glucose oxidation
[4].
The aim of this study is to explore how the HFD initiates the sig-
nalling pathways in mediating the myocardial energy metabolism
in mice early in the course of obesity development.2. Materials and methods
All animals received care and treatment according to Canadian
Council on Animal Care and University of Alberta Health Sciences
Animal Welfare Committee. Male C57BL/6 mice of 8 week of age
were placed on either a HFD (60% calories from lard) or a low fatlsevier B.V. All rights reserved.
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10 day or 3 week period. Hearts were excised and immediately fro-
zen in liquid N2 for biochemical analyses or perfused in the isolated
working mode.
2.1. Heart perfusions
Isolated working hearts were perfused with Krebs–Henseleit
solution containing 1 mM lactate, 5 mM glucose, 0.8 mM palmi-
tate, 3% fatty acid free bovine serum albumin, and 2.5 mM free
Ca2+. To measure fatty acid oxidation and lactate oxidation rates,
hearts were subjected to a 60 min perfusion with perfusate con-
taining [9,10-3H]palmitate and [U-14C]lactate. To measure rates
of glycolysis and glucose oxidation, another series of hearts were
perfusated in Krebs–Henseleit solution containing [5-3H] glucose
and [U-14C] glucose. Oxidation and glycolytic rates were deter-
mined simultaneously by quantitative collection of 14CO2 and
3H2O produced by the hearts. The perfusions were performed at
a left atrial preload of 11.5 mmHg and an aortic afterload of
50 mmHg. Heart rate, cardiac output, and cardiac work were mea-
sured as described previously [22].
2.2. Assessment of b-hydroxylacyl CoA dehydrogenase and citrate
synthase activity
The activity of b-hydroxylacyl CoA dehydrogenase and citrate
synthase was measured based on the continuous spectrophoto-
metric rate determination, following the reduction of NAD+ atFig. 1. Altered myocardial energy metabolism in mice fed a HFD for 10 days. In the iso
insulin. (A) Rates of glucose oxidation. (B) Rates of lactate oxidation. (C) Rates of
dehydrogenase. (F) Myocardial malonyl CoA level. Values represent mean ± S.E.M. (n = 5340 nm [23] or the increased production of TNB at 412 nm [22],
respectively.
2.3. Myocardial triacylglycerol (TG), malonyl-CoA, long chain-CoA, and
ceramide determination
Myocardial TG was quantitated colorimetrically with an enzy-
matic assay (Wako Pure Chemical Industries) [22]. Myocardial
malonyl-CoA, long chain-CoA and ceramide were assessed by HPLC
[22].
2.4. Pyruvate dehydrogenase complex (PDC) activity
Measurement of PDC was performed using a radioisotopic-cou-
pled enzyme assay following acetyl-CoA production, as previously
described [24].
2.5. Antibodies for immunoblot analysis
Antibodies for phospho-Rb(s780), phosphor-cyclin D1(Thr
286)/total cyclin D1, eIF4E, phosphor-4EBP1, phosphor-eIF2a/to-
tal eIF2a and lamin A were purchased from Cell Signaling Tech-
nology (Beverly, MA). Antibodies for CDK4 and PDK4 were
obtained from Abcam, while anti-E2F1 and anti-actin were from
Santa Cruz Biotechnology. The immunoreactive bands were quan-
tiﬁed by scanning densitometry with ImageJ image analysis
software.lated working hearts, the basal energy metabolism was assessed in the absence of
glycolysis. (D) Rates of palmitate oxidation. (E) Activity of b-hydroxylacyl CoA
). ⁄P < 0.05, signiﬁcantly different from the LFD.
Fig. 2. Effect of HFD on myocardial PDC, PDK4, citrate synthase activity and lipids. (A) Active and total PDH activity. (B) Expression of PDK4. (C) Citrate synthase activity. (D)
Levels of triacylglycerol (TG). (E) Levels of long chain acyl CoA. (F) Levels of ceramide. Values represent mean ± S.E.M. (n = 5). ⁄P < 0.05, signiﬁcantly different from the LFD.
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Levels of mRNA were quantiﬁed by TaqMan Real time RT-PCR
using 18S RNA as the internal control. The primers and probes
were purchased from Applied Biosystems (ABI) Canada. The primer
and probe sequences for mouse CDK4 were designated by using
‘‘Primer Express’’ software from ABI. Forward Primer: GAG-
GCCTTTGAACATCCCAA. Reverse primer: TCAGTTCGGGAAGTAGCA-
CAGA; Probe: TTGTACGGCTGATGGAT.
2.7. Statistical analysis
All data are presented as the mean ± S.E.M. Statistical analysis of
the data was performed with the use of a 2-tailed Student t-test to
determine the statistical signiﬁcance of differences between the
HFD mice and LFD mice. P < 0.05 was considered signiﬁcant.
3. Results
3.1. Cardiac carbohydrate oxidation rates are reduced in mice
subjected to 10 days of a HFD
To examine what early cardiac energy metabolic changes oc-
curred with a HFD, isolated working heart perfusions were per-formed in mice after 10 days on a HFD. A decrease in the glucose
oxidation (Fig. 1A) and lactate oxidation rates (Fig. 1B) was seen
in mice subjected to a HFD, compared to LFD controls. In contrast,
rates of glycolysis (Fig. 1C) and palmitate oxidation (Fig. 1D) were
unaffected. Consistent with the lack of changes in fatty acid oxida-
tion, the activity of b-hydroxylacyl CoA dehydrogenase (Fig. 1E), a
key enzyme involved in fatty acid b-oxidation, and the levels of
malonyl CoA, a key molecule preventing fatty acid CoA from enter-
ing mitochondria (Fig. 1F), were preserved.
3.2. Inactivation of myocardial PDC results from a HFD-induced up-
regulation of PDK4 expression
Reduction in glucose uptake or suppression in PDC activity
could account for the decrease in carbohydrate oxidation rates.
However, the expression of glucose transporter 1 and 4 was unal-
tered by the diet (data not shown), and glycolytic rates were not
signiﬁcantly decreased. In contrast, the amount of active PDC
was signiﬁcantly decreased in mice fed a HFD compared to LFD
controls (Fig. 2A). This occurred despite no differences in the total
PDC activity (Fig. 2A), suggesting an enhanced phosphorylation
and inhibition of PDC in the HFD mice hearts. This notion is further
supported by an enhanced PDK4 protein expression in mice fed a
HFD (Fig. 2B). In addition, neither mitochondrial citrate synthase
Table 1
Cardiac function was unaltered in mice fed a HFD for 10 days.
Control (low fat 4%,
n = 15)
High fat (60%,
n = 15)
Cardiac work (ml ⁄ mmHg/
min)
6.9 ± 0.30 7.0 ± 0.3
Cardiac output (mL/min) 10 ± 0.47 10.2 ± 0.48
Aortic ﬂow (mL/min) 6.7 ± 0.42 6.6 ± 0.47
Cardiac power (mJ/min) 76 ± 3.9 77 ± 3.5
Statistic analysis of the data was performed with a 2-tailed Student t-test.
L. Zhang et al. / FEBS Letters 586 (2012) 996–1003 999activity (Fig. 2C), the level of various myocardial lipids (Fig. 2D–F),
nor cardiac function (Table 1) was altered by the diet. Thus, the
HFD-induced early reduction in carbohydrate oxidation rates is
not the result of lipid accumulation or mitochondrial and cardiacp-Rb
actin
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LFD        HFD
n-E2F1
Lamin A
A
C
E
Fig. 3. Effect of HFD on the expression of myocardial E2F1, p-Rb(s780) and CDK4. (A) Exp
(D) expression of CDK4 in the nucleus. (E) Expression of CDK4mRNA. (F) Ratio of p-cyclin
⁄P < 0.05, signiﬁcantly different from the LFD.dysfunction, but a result of suppression of PDC activity due to
induction of cardiac PDK4.
3.3. Nuclear translocation of cardiac E2F1 was enhanced concomitant
with the induction of PDK4
Consistent with other studies [2], HFD-induced nuclear translo-
cation of PPARa and PGC-1a, known to modulate PDK4, was not
observed in mice after a HFD (data not shown), suggesting an alter-
ative pathway(s) involved in the increased myocardial PDK4 tran-
scription. We therefore examined what effect a HFD had on the
expression of cardiac E2F1, a newly identiﬁed molecule for direct
regulating the gene encoding PDK4 [4]. The abundance of nuclear
E2F1 protein was signiﬁcantly enhanced in mice fed a HFD com-
pared to LFD controls (Fig. 3A). This likely occurred as a result ofn-CDK4
lamin A
LFD          HFD
p-cyclin D1
t-cyclin D1
actin
LFD             HFD
B
D
F
ression of E2F1 in the nucleus. (B) Levels of E2F1 mRNA. (C) Phosphorylation of Rb.
D1 at Thr286 to the total cyclin D1 in cytosol. Values represent mean ± S.E.M. (n = 5).
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level of cardiac E2F1 was unaltered (Fig. 3B). This is supported by
the up-regulation of p-Rb, at residue serine 780 (s780) (Fig. 3C),
a well known indicator for nuclear translocation of E2F1 [12,13].
Consistent with the notion that p-Rb (s780) is a speciﬁc target of
CDK4 [14], the HFD-induced accumulation of nuclear CDK4 was
also observed (Fig. 3D). This appears to be a result of a HFD-in-
duced nuclear translocation, as CDK4 mRNA levels were unaltered
by the HFD (Fig. 3E). In addition, it has been demonstrated that nu-
clear translocation of CDK4 results in an enhanced phosphorylation
of cyclin D1(p-cyclin D1) at residue threonine 286 (T286) [25,26].
Indeed, increased phosphorylation of cyclin D1 was seen in the
hearts of mice on a HFD compared to LFD controls (Fig. 3F). Thus,
the data is consistent with cardiac E2F1 being activated due to a
HFD-induced nuclear translocation of CDK4 resulting in a phos-
phorylation of Rb (s780).
3.4. Nuclear translocation of CDK4 by a HFD is initiated via accelerated
translation of cyclin D1
It is known that nuclear translocation of CDK4 occurs when the
abundance of cytosolic cyclin D1 is enhanced [27]. We questioned
whether HFD initiates this process via a transcriptional or a trans-
lational regulation of cyclin D1. In contrast to the unaltered mRNA
level of cardiac cyclin D1 (Fig. 4A), the abundance of cytosolic cy-
clin D1 was decreased (Fig. 4B), concomitant with an increase in
the expression of nuclear cyclin D1 (Fig. 4B) in the mice fed a
HFD compared to LFD controls. This suggests a translational mech-A
C
D
p-4EBP1
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Fig. 4. Effect of HFD on enhancing the abundance of myocardial cyclin D1 and activating
and nucleus. (C) Expression of p-4EBP1. (D) Expression of p-eIF2a. Values are mean ± S.anism underlying HFD-induced regulation of cyclin D1. To further
prove this, activation of eukaryotic initiation factor 4E (eIF4E),
known to play a speciﬁc role in stimulating translation of cyclin
D1 [19,20], was assessed by its protein expression and the phos-
phorylation of eukaryotic initiation factor 4E-binding protein-1
(4EBP1) [28]. A signiﬁcantly increased phosphorylation of cardiac
4EBP1 was observed in the HFD mice (Fig. 4C and D), despite an
unaltered eIF4E protein. In addition, activation of eIF2a kinases
can lead to the phosphorylation of 4EBP1 [29]. Similar to p-
4EBP1, phosphorylation of eIF2a was also signiﬁcantly enhanced
by the HFD (Fig. 4E). Hence, HFD-induced signals initiate complex
formation of cyclin D and CDK4, most likely via accelerating the
translation of cyclin D1.
3.5. Up-regulation of PDK4 occurs in conjunction with time-dependent
activation of E2F1
To investigate whether the parallel elevation of E2F1 and PDK4
seen in hearts after 10 days of a HFD persists with longer periods of
a HFD, the period of HFD was prolonged to 3 weeks. Similar to
10 days of HFD, the nuclear expression of E2F1 was signiﬁcantly
enhanced (3.97 ± 0.45 vs 1.98 ± 0.21 in the LFD, P < 0.05). In line
with this, the expression of p-Rb (s780) (Fig. 5A) and PDK4
(Fig. 5B) was stepwise elevated in the same fashion after a HFD,
concomitant with a decrease in glucose oxidation rates (Fig. 5C).
In addition, the upstreammolecules involved in accelerating trans-
lation of cyclin D1, such as p-eIF4E (Fig. 5D) and p-eIF2a (Fig. 5E),
were also time-dependently up-regulated by the short term HFD.B LFD HFD LFD HFD
c-cyclin D1
actin
n-cyclinD1
lamin A
HFD
eIF4E. (A) Expression of cyclin D1 mRNA. (B) Expression of cyclin D1 in the cytosol
E.M., ⁄P < 0.05, ⁄⁄P < 0.01, signiﬁcantly different from the LFD.
Fig. 5. Alterations of myocardial p-Rb, PDK4 and p-4EBP1 in mice after 10 days and 3 weeks of a HFD. (A) Time dependent up-regulation of p-Rb (s780). (B) Time dependent
up-regulation of PDK4. (C) Time-dependent changes of glucose oxidation rates. (D) Time-dependent expression of p-4EBP1. (E) Time-dependent expression of p-eIF2a. Values
are mean ± S.E.M., ⁄P < 0.05, ⁄⁄P < 0.01, signiﬁcantly different from the LFD.
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This study provides a number of novel ﬁndings regarding the ef-
fects of a HFD on early alterations in energy metabolism in the
heart. This includes: (1) an early and selective decrease in carbohy-
drate oxidation occurs, (2) cardiac E2F1, known as controlling the
gene encoding PDK4, accumulates in the nucleus following 10 days
of a HFD, coincident with the up-regulation of PDK4 and down-reg-
ulation of PDC activity, (3) HFD-induced nuclear translocation of
CDK4 and cyclin D1 is responsible for the nuclear accumulation
of E2F1, through CDK4-related phosphorylating Rb thereby releas-
ing E2F1, and (4) nuclear translocation of cyclin D1 occurs due to
HFD-induced activation of eukaryotic initiation factors via acceler-
ating translation of cyclin D1. The signiﬁcance of these ﬁndings is
that we describe a new mechanism through which HFD-inducedactivation of cardiac eukaryotic initiation factors may couple cell
cycle regulators and PDK4 to control mitochondrial carbohydrate
oxidation as an early response to a HFD.
To support the conclusion that myocardial PDK4 is a major
player involved in the HFD-induced reduction in carbohydrate oxi-
dation, we demonstrated an early suppression of PDC activity in
mice after 10 days of a HFD. The possibility, that membrane distri-
bution of glucose transporters could be a causal factor [2] is ruled
out since glycolysis was not depressed, and lactate uptake and oxi-
dation occur independent of glucose transporters. As a result the
HFD-induced reduction of cardiac glucose and lactate oxidation
rates is likely due to a decreased conversion of pyruvate to acetyl
CoA by PDC activity. Thus, the HFD-induced up-regulation of myo-
cardial PDK4 likely represents a critical mechanism for the early
decrease in myocardial lactate and glucose oxidation. In addition,
1002 L. Zhang et al. / FEBS Letters 586 (2012) 996–1003we demonstrate that the level of nuclear E2F1 is signiﬁcantly ele-
vated. This appears to be the result of a HFD-induced nuclear trans-
location of E2F1, since E2F1 mRNA level is unaffected by the diet.
Instead of determining E2F1 transcriptional activity, we took
advantage of the speciﬁc antibody raised against p-Rb (s780),
based on the fact that up-regulation of p-Rb (s780) is a reliable
indicator of E2F1 activation [14,30]. We demonstrate a HFD-in-
duced up-regulation of p-Rb (s780). Furthermore, phosphorylating
Rb(s780) occurs in a CDK4-speciﬁc manner in vivo [12–14]. To be
active, CDK4 needs to form a complex with cyclin D1, in which in-
creased abundance of cytosolic free cyclin D1 is a prerequisite [15].
On the basis of unchanged cyclin D1 mRNA levels, and the speciﬁc
role of eIF4E in stimulating translation of cyclin D1 [19,20], we
demonstrate that the activity of eIF4E, which is largely controlled
by phosphorylation of 4EBP1 [28], is enhanced in a time-depen-
dent manner. Hence, the HFD induced signals initiate translocation
of E2F1, thereby up-regulating PDK4, most likely through acceler-
ating the translation of cyclin D1 via activating eIF4E.
In current study, we are unable to explore whether decreas-
ing E2F1/p-Rb decreases PDK4 expression in HFD mice. However,
genetic manipulations, such as E2F1 knockout (E2F1/) mice,
have shown a blunted PDK expression and improved glucose
oxidation in isolated hearts [4]. In contrast, exogenous E2F1
over-expression has been shown to up-regulate PDK4 in mouse
myoblasts, in IMR90 ﬁbroblasts, and in C2C12 cells [4], while
also reducing glucose oxidation in human AC16 cells [31]. In
addition, a markedly induced PDK4 expression also occurs in
Rb-deﬁcient mouse embryo ﬁbroblasts, which strongly suggests
a transcriptional requirement of PDK4 by induction of E2F1 [4].
In addition, we have also observed in angiotensin II-induced
hypertrophic mouse hearts that impaired glucose oxidation,
due to elevated PDK4 expression, is accompanied by a nuclear
accumulation of cardiac E2F1 and an induction in phosphory-
lated Rb (s780) (Lopaschuk et al. unpublished data). Importantly,
reversible regulation of glucose oxidation in AngII-induced
hypertrophic mouse heart occurs in conjunction with the
down-regulation of PDK4, E2F1 and p-Rb (s780) (Lopaschuk et
al. unpublished data). An interesting ﬁnding from our study is
that the nuclear translocation of PPARa and PGC-1a, known to
modulate PDK4 promoter [6,7], was not affected by the diet,
whereas the nuclear translocation of E2F1 was enhanced withFig. 6. Proposed pathway for suppressed myocardial carbohydrate oxidation rates
by a short term of HFD. HFD-induced signals activates eIF4E to enhance the
translation of cytosolic free cyclin D1. As a result, nuclear translocation of cyclin D1
with its catalytic partner CDK4 phosphorylates Rb, thereby releasing E2F1 to the
nucleus where up-regulating PDK4 expression occurs. Thus, up-regulation of PDK4
inhibits PDC activity thereby restricting the inﬂux of acetyl CoA into mitochondria
and reducing carbohydrates oxidation.stepwise increased expression of p-Rb and PDK4 and decreased
glucose oxidation after 10 days to 3 week of a HFD. Thus, we
propose that the biological relevance of E2F1 in regulating
PDK4 is important.
A proposed signaling pathway for short-term HFD-induced
down-regulation of carbohydrate oxidation is depicted in Fig. 6.
HFD-induced signals enhance the level of cytosolic free cyclin D1,
most likely through accelerating translation of cyclin D1 via acti-
vating cardiac eIF4E. As a result, nuclear translocation of cyclin
D1 with its partner CDK4 phosphorylates Rb at s780, thereby
releasing E2F1 to the nucleus, where it up-regulates PDK4 expres-
sion. At this point, the function of CDK4 and cyclin D1 is no longer
required [15], and nuclear export of cyclin D1 leads to enhanced
expression of p-cyclin D1 [15,25]. Our data offers an explanation
for the ﬁndings that cardiac PDK4 is increased, which is very often
one of the proteins that displays the largest changes in expression
in response to metabolic disease or conditions that affect cardiac
metabolism. A limitation of our study is that we are unable to ex-
tend the studies by modulating the key regulatory components
such as 4EBP1 or CDK4 in vivo, to further strengthen our conclu-
sions. It is important to emphasize, however, that modulation of
E2F1 in hearts might be exploited therapeutically to increase glu-
cose oxidation in obesity and diabetes.Acknowledgments
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